Cargando…
The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
OBJECTIVE: Diagnosis classification and risk stratification are crucial in the prognosis prediction and treatment selection of acute myeloid leukemia (AML). Here, we used a database of 536 AML patients to compare the 4th and 5th WHO classifications and the 2017 and 2022 versions of ELN guidance. MET...
Autores principales: | Wang, Xiaoning, Wang, Jie, Wei, Suhua, Zhao, Juan, Xin, Beibei, Li, Guoqing, Zhao, Jing, Wu, Di, Luo, Minna, Zhao, Sijie, Chen, Ying, Liu, Haibo, Zhang, Hailing, Wang, Jingcheng, Wang, Wenjuan, Wang, Huaiyu, Xiong, Hui, He, Pengcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332310/ https://www.ncbi.nlm.nih.gov/pubmed/37435533 http://dx.doi.org/10.3389/fmed.2023.1165445 |
Ejemplares similares
-
Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022
por: Bouligny, Ian M., et al.
Publicado: (2023) -
Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma
por: Zhao, Jing, et al.
Publicado: (2022) -
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network
por: Termini, Christina M., et al.
Publicado: (2023) -
Experiences with a researcher-centric ELN
por: Badiola, Katrina A., et al.
Publicado: (2015) -
The New ELN Recommendations for Treating CML
por: Hehlmann, Rüdiger
Publicado: (2020)